Pharmaceuticals

Plasma Fractionation Market Size and Demand Forecast 2026–2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plasma fractionation market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Plasma Fractionation Market in 2026, and what figure is it projected to hit by 2030?

The plasma fractionation market has witnessed rapid growth in recent years. Its valuation is anticipated to climb from $34.14 billion in 2025 to $37.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.2%. The expansion observed in the past period is attributable to several factors, including an increased demand for immunoglobulins, a higher prevalence of hematological disorders, advancements in plasma fractionation technology, the broadening of hospital and clinical infrastructure, and a surge in awareness concerning plasma-derived therapies.

The plasma fractionation market is projected to experience swift expansion in the coming years, anticipated to reach a value of $55.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. The growth during the projected timeframe stems from factors such as the growing embrace of precision medicine, the incorporation of AI into plasma manufacturing processes, the broadening of worldwide biopharmaceutical partnerships, increased funding for plasma collection centers, and the creation of innovative plasma-derived treatments. Key trends anticipated for this forecast period encompass advanced methodologies in plasma fractionation, diversification of biopharmaceutical products, improved quality control measures alongside regulatory adherence, the enlargement of contract manufacturing organizations (CMOs/CDMOs), and efforts to optimize the supply chain for plasma products.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Drivers Are Affecting Market Participation In The Plasma Fractionation Market?

The increasing prevalence of chronic diseases is anticipated to drive the future expansion of the plasma fractionation market. Chronic conditions are defined as ailments lasting one year or more, requiring ongoing medical attention, and include examples such as heart disease, cancer, and diabetes. Treating patients with chronic diseases using plasma products helps reduce morbidity, improves their quality of life, and is cost-effective, which will, in turn, escalate the demand for plasma fractionation. For instance, in March 2025, GOV.UK, a UK-based non-profit government organization, reported that the prevalence of type 2 diabetes among adults aged 17 and over in England was 7.0% in March 2024, showing an increase from 6.8% in March 2023. Therefore, a growing number of chronic diseases across all age groups is expected to propel the plasma fractionation market growth.

What Segment Categories Are Covered In The Plasma Fractionation Market?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Which Trends Are Guiding The Evolution Of The Plasma Fractionation Market?

Leading companies in the market are integrating novel technologies, such as high-tech facility operations that transform donated human plasma into crucial medicines, utilizing advanced methods to enhance both efficiency and safety. For instance, in March 2023, CSL Behring, a German-based firm, unveiled a new $470 million plasma fractionation facility. This facility employs cutting-edge technology to improve the efficacy and safety of plasma processing, thereby ensuring higher quality and more dependable medications. By boosting the supply of these vital medicines, the plant aids in satisfying the increasing demand, guaranteeing more patients receive life-saving treatments. Its sophisticated automation and self-cleaning systems significantly lower the risk of contamination and elevate overall hygienic standards, thereby improving patient safety.

Which Leading Companies Dominate The Plasma Fractionation Market Share?

Major companies operating in the plasma fractionation market are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

How Does The Plasma Fractionation Market Perform Across Major Global Regions?

North America was the largest region in the plasma fractionation market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plasma Fractionation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Browse Through More Reports Similar to the Global Plasma Fractionation Market 2026, By The Business Research Company

Plasma Fractionation Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Plasma Powder Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Blood Plasma Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795